Supplementary Data files S1 a_f from Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy
Résumé fourni par la source
Excel spreadsheets showing: (S1a) the differential expression analysis between mesenchymal vs proneural tumors; (S1b) the differential expression analysis between classical vs mesenchymal tumors; (S1c) the differential expression analysis between classical vs proneural tumors; (S1d) classification of tumor samples based on the RNA-Seq results into the three TCGA molecular subtypes (according to the GlioVis algorithms KNN, SVM, and ssGSEA) and classification according to the IGS clusters; (S1e) immunohistochemical results of samples classified in the three TCGA molecular subtypes (according to the GlioVis algorithms KNN, SVM, and ssGSEA) and IGS clusters; and (S1f) results of the gene fusion analysis in the tumor samples, the molecular subtype of the tumor (according to the GlioVis algorithms KNN, SVM, and ssGSEA), and the tumor IGS clusters
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Supplementary Data files S1 a_f from Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy
- Date Crossref
- 31/03/2023
- Éditeur
- American Association for Cancer Research (AACR)
- Type
- posted-content
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.